Kantarjian Hagop
Leukemia Department, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 428, Houston, TX 77030, USA.
Hematology. 2012 Apr;17 Suppl 1:S52-4. doi: 10.1179/102453312X13336169155538.
Monoclonal antibodies targeting surface markers in acute lymphocytic leukemia (CD19, CD20 and CD22) are showing promising results and are reviewed.
靶向急性淋巴细胞白血病表面标志物(CD19、CD20和CD22)的单克隆抗体正显示出有前景的结果,并在此进行综述。